|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 800 I STREET, NW |
Address2 |
|
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3173-12
|
||||||||
|
6. House ID# 333530000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Donald Hoppert |
Date | 4/19/2021 1:42:12 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Support $93 million for the Centers for Disease Control and Preventions Agency for Toxic Substances and Disease Registry in the FY 2022.
Support $500 million in funding for the Agency for Healthcare and Research and Quality in FY 2022.
Support a significant, long-term investment in public health infrastructure in future legislation to speed the response to the COVID-19 pandemic.
Support the Public Health Infrastructure Saves Lives Act.
Support $10 billion for the Centers for Disease Control and Prevention in FY 2022.
Support $9.2 billion for the Health Resources and Services Administration in FY 2022.
Support the American Rescue Plan Act of 2021.
Support $50 million for CDC's Climate and Health Program in FY 2022.
Support $50 million in FY 2022 for gun violence prevention research at CDC and NIH.
Support $322 million for CDC's National Center for Environmental Health in FY 2022.
Support $93 million for the Agency for Toxic Substances and Disease Registry in FY 2022.
Support $310 million in funding for the CDC Office on Smoking and Health in FY 2022.
Support FY 2022 funding for programming and research to prevent older adult falls.
Support support of full funding of immunization-related activities at the Department of Health and Human Services.
Support the Immunization Infrastructure Modernization Act.
Support increased funding for antimicrobial resistance programs at CDC, NIH, ASPR, FDA, USDA, USAID and DOD in FY 2022.
Support $310 million in funding for the CDC Office on Smoking and Health in fiscal year 2022.
Support $750 million for the Title V Maternal and Child Health (MCH) Services Block Grant in FY22.
Support $1.51 billion for the Health Resources and Services Administration (HRSA) Title VII health professions and Title VIII nursing workforce development programs in FY 2022.
Support adequate funding for HIV and STI prevention and treatment programs.
Support adequate funding for maternal health programs at CDC, NIH and HRSA.
Support $100 million for CDCs Surveillance for Emerging Threats to Mothers and Babies Network in FY22.
Support $50 million for the CDC Social Determinants of Health program in FY22.
Support the Public Health Funding Prevents Pandemics Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Support the Corrections Data Transparency Act.
Support the Community Immunity During COVID-19 Act.
Support the Providing Urgent Maternal Protections for Nursing Mothers Act.
Support the Protecting Seniors Through Immunization Act of 2021.
Support rescission of the Section 1115 Medicaid work requirements demonstrations.
Support for key childrens nutrition provisions in pandemic recovery legislation.
Support for child nutrition programs that ensure vulnerable families receive nutritious meals for their children during and after the COVID-19 pandemic.
Support the Black Maternal Health Momnibus Act.
Support the Medicaid Reentry Act.
Support the Summer Meals Act.
Support the Health Enterprise Zones Act of 2021.
Support the Public Health Infrastructure Saves Lives Act.
Support the Providing Urgent Maternal Protections (PUMP) for Nursing Mothers Act.
Support the Future Advancement of Academic Nursing Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Vice President of the U.S., White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Support the Family and Medical Insurance Leave (FAMILY) Act.
Support the Workplace Violence Prevention for Health Care and Social Services Workers Act.
Support the Raise the Wage Act of 2021.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Support the Quit Because of COVID-19 Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Support S. 614, legislation to improve the transportation alternatives program.
Support H.R. 463, the Transportation Alternatives Enhancement Act.
Support for transportation policies that reduce both harmful air pollution and climate pollution.
Support the Safe Routes to School Expansion Act.
Support H.R. 508, the SAFE Streets Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CIV
16. Specific lobbying issues
Support H.R. 5, the Equality Act.
Support H.R. 1280, the George Floyd Justice in Policing Act of 2021.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
|
Jordan |
Wolfe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Support H.R. 8, the Bipartisan Background Checks Act of 2021, and S. 529, the Background Check Expansion Act.
Support H.R. 1446, the Enhanced Background Checks Act of 2021.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
Support the nomination of Xavier Becerra as Secretary of the U.S. Department of Health and Human Services.
Support the nomination of Rachel Levine as Assistant Secretary for Health.
Support the nomination of Vivek Murthy as U.S. Surgeon General.
Support the nomination of Michael Regan as Administrator of the U.S. Environmental Protection Agency.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Donald |
Hoppert |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |